chevron_leftBack
As of 6 June 2026, Cellromax Science Co., Ltd. has a market cap of $38.18M USD, ranking #32530 globally and #1936 in South Korea.
It ranks #2939 in the Healthcare sector, and #173 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$38.18MUSD
58.52B KRW
Enterprise Value
$33.46MUSD
51.29B KRW
Revenue (TTM)
$14.47MUSD
22.18B KRW
EBITDA (TTM)
$2.16MUSD
3.31B KRW
Net Income (TTM)
$1.94MUSD
2.97B KRW
EBITDA Margin
15%
Profit Margin
13%
PE Ratio
20.3
PS Ratio
2.6
PB Ratio
1.2
EV/EBITDA
15.5
Company Profile
Country (HQ)
Sector
Healthcare
Employees
35
Founded
2022
Website
hanwha-plus-no3spac.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.4% | 1.1% | 5.6% | 2.5% | 1.1% | 3.5% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
471820
주식회사 셀로맥스사이언스
ISIN: KR7471820001
Shares Out.:
Shares Outstanding:
11.165M1
Shares Float:
1.721M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
5,300 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Cellromax Science Co., Ltd.
Cellromax Science Co., Ltd. focuses to merge with other companies. The company was founded in 2022 and is based in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 317450
|
$539.11M
1K%
826.36B KRW
|
8.4
|
|
KRX: 220100
|
$278.08M
628%
426.25B KRW
|
-
|
|
KRX: 200130
|
$218.56M
473%
335.01B KRW
|
-
|
|
KRX: 009290
|
$203.29M
433%
311.61B KRW
|
16.3
|
|
KRX: 194700
|
$167.22M
338%
256.31B KRW
|
7.4
|
|
KRX: 011040
|
$98.78M
159%
151.41B KRW
|
17.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.66B
99K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
77K%
|
-
|
|
SHE: 002001
|
$15.86B
41K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.12B
29K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.0B
29K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.1B
24K%
61.6B CNY
|
80.6
|
chevron_leftBack